Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells

International Journal of Cancer

Volumn 128, Issue 7, 2011, Pages 1570-1584

  Ween, Miranda P ^a   Lokman, Noor A ^a   Hoffmann, Peter ^a   Rodgers, Raymond J ^a   Ricciardelli, Carmela ^a   Oehler, Martin K ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

IG H3; adhesion; invasion; metastasis; motility; ovarian cancer; peritoneum; TGFBIp

Indexed keywords

PLASMIN INHIBITOR; RECOMBINANT PROTEIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CANCER INVASION; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL MOTILITY; CELL STRAIN; CELL STRAIN LP 9; CELL STRAIN OVCAR 5; CELL STRAIN SKOV 3; COCULTURE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; METASTASIS POTENTIAL; OVARY CANCER; OVARY CARCINOMA; OVARY CELL; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; OVARY; PERITONEAL NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 79551488768     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25494     Document Type: Article

References (53)

1. Stewart BW,. WHO world cancer reported. Lyon, France: IARC Press, 2003.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
3. Rubin SC, Randall TC, Armstrong KA, Chi DS, Hoskins WJ,. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol 1999; 93: 21-4.
4. Gardner MJ, Jones LM, Catterall JB, Turner GA,. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett 1995; 91: 229-34.
5. Freedman RS, Deavers M, Liu J, Wang E,. Peritoneal inflammation-a microenvironment for epithelial ovarian cancer (EOC). J Transl Med 2004; 2: 23.
6. Strobel T, Cannistra SA,. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 1999; 73: 362-7.
7. Ricciardelli C, Rodgers RJ,. Extracellular matrix of ovarian tumors. Semin Reprod Med 2006; 24: 270-82.
8. Said NA, Najwer I, Socha MJ, Fulton DJ, Mok SC, Motamed K,. SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk. Neoplasia 2007; 9: 23-35.
9. Heyman L, Kellouche S, Fernandes J, Dutoit S, Poulain L, Carreiras F,. Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro. Tumour Biol 2008; 29: 231-44.
10. Kenny HA, Kaur S, Coussens LM, Lengyel E,. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008; 118: 1367-79.
11. Gardner MJ, Catterall JB, Jones LM, Turner GA,. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin Exp Metastasis 1996; 14: 325-34.
12. Thapa N, Lee BH, Kim IS,. TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta. Int J Biochem Cell Biol 2007; 39: 2183-94.
13. LeBaron RG, Bezverkov KI, Zimber MP, Pavelec R, Skonier J, Purchio AF,. Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 1995; 104: 844-9.
14. Kim JE, Kim SJ, Lee BH, Park RW, Kim KS, Kim IS,. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. J Biol Chem 2000; 275: 30907-15.
15. Zhao Y, El-Gabry M, Hei TK,. Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells. Mol Carcinog 2006; 45: 84-92.
16. Calaf GM, Echiburu-Chau C, Zhao YL, Hei TK,. BigH3 protein expression as a marker for breast cancer. Int J Mol Med 2008; 21: 561-8.
17. Sasaki H, Kobayashi Y, Nakashima Y, Moriyama S, Yukiue H, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y,. Beta IGH3, a TGF-beta inducible gene, is overexpressed in lung cancer. Jpn J Clin Oncol 2002; 32: 85-9.
18. Ivanov SV, Ivanova AV, Salnikow K, Timofeeva O, Subramaniam M, Lerman MI,. Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors. Biochem Biophys Res Commun 2008; 370: 536-40.
19. Yamanaka M, Kimura F, Kagata Y, Kondoh N, Asano T, Yamamoto M, Hayakawa M,. BIGH3 is overexpressed in clear cell renal cell carcinoma. Oncol Rep 2008; 19: 865-74. (Pubitemid 351802653)
20. Hourihan RN, O'Sullivan GC, Morgan JG,. Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 2003; 23: 161-5.
21. Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P, Edelhoff S, Disteche C, Neubauer M, Marquardt H, et al. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 1994; 13: 571-84.
22. Zhao YL, Piao CQ, Hei TK,. Overexpression of Betaig-h3 gene downregulates integrin alpha5beta1 and suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells. Br J Cancer 2002; 86: 1923-8.
23. Kim MO, Yun SJ, Kim IS, Sohn S, Lee EH,. Transforming growth factor-beta-inducible gene-h3 (beta(ig)-h3) promotes cell adhesion of human astrocytoma cells in vitro: implication of alpha6beta4 integrin. Neurosci Lett 2003; 336: 93-6.
24. Tang J, Zhou HW, Jiang JL, Yang XM, Li Y, Zhang HX, Chen ZN, Guo WP,. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells. Exp Biol Med (Maywood) 2007; 232: 344-52.
25. Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, Cheng AW, Lin F, Jiang S, Yeatman TJ, Wang XF,. Extracellular matrix protein {beta}ig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 2008; 22: 308-21.
26. Tang J, Wu YM, Zhao P, Jiang JL, Chen ZN,. Betaig-h3 interacts with alpha3beta1 integrin to promote adhesion and migration of human hepatoma cells. Exp Biol Med (Maywood) 2009; 234: 35-9.
27. Walker G, MacLeod K, Williams AR, Cameron DA, Smyth JF, Langdon SP,. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. Gynecol Oncol 2007; 106: 461-8.
28. Ahmed AA, Mills AD, Ibrahim AE, Temple J, Blenkiron C, Vias M, Massie CE, Iyer NG, McGeoch A, Crawford R, Nicke B, Downward J, et al. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 2007; 12: 514-27.
29. Condina MR, Guthridge MA, McColl SR, Hoffmann P,. A sensitive magnetic bead method for the detection and identification of tyrosine phosphorylation in proteins by MALDI-TOF/TOF MS. Proteomics 2009; 9: 3047-57.
30. Ricciardelli C, Choong CS, Buchanan G, Vivekanandan S, Neufing P, Stahl J, Marshall VR, Horsfall DJ, Tilley WD,. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate 2005; 63: 19-28.
31. Galardy RE, Grobelny D, Foellmer HG, Fernandez LA,. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2- (hydroxamidocarbonymethyl)-4-methylpentanoyl)]- L -tryptophan methylamide. Cancer Res 1994; 54: 4715-8.
32. Andersen RB, Karring H, Moller-Pedersen T, Valnickova Z, Thogersen IB, Hedegaard CJ, Kristensen T, Klintworth GK, Enghild JJ,. Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas. Biochemistry 2004; 43: 16374-84.
33. Zhao YL, Piao CQ, Hei TK,. Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells. Oncogene 2002; 21: 7471-7.
34. Shao G, Berenguer J, Borczuk AC, Powell CA, Hei TK, Zhao Y,. Epigenetic inactivation of Betaig-h3 gene in human cancer cells. Cancer Res 2006; 66: 4566-73.
35. Kim JE, Kim SJ, Jeong HW, Lee BH, Choi JY, Park RW, Park JY, Kim IS,. RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis. Oncogene 2003; 22: 2045-53.
36. Becker J, Erdlenbruch B, Noskova I, Schramm A, Aumailley M, Schorderet DF, Schweigerer L,. Keratoepithelin suppresses the progression of experimental human neuroblastomas. Cancer Res 2006; 66: 5314-21.
37. Zhang Y, Wen G, Shao G, Wang C, Lin C, Fang H, Balajee AS, Bhagat G, Hei TK, Zhao Y,. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res 2009; 69: 37-44.
38. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH,. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 2001; 61: 5168-78.
39. Schneider D, Kleeff J, Berberat PO, Zhu Z, Korc M, Friess H, Buchler MW,. Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim Biophys Acta 2002; 1588: 1-6.
40. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD,. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 2002; 62: 5358-64.
41. Irigoyen M, Anso E, Salvo E, de las Herrerias JD, Martinez-Irujo JJ, Rouzaut A,. TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions. Cell Mol Life Sci 2008; 65: 2244-55.
42. Nam JO, Jeong HW, Lee BH, Park RW, Kim IS,. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin. Cancer Res 2005; 65: 4153-61.
43. Cannistra SA, Ottensmeier C, Niloff J, Orta B, DiCarlo J,. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol Oncol 1995; 58: 216-25.
44. Bae JS, Lee SH, Kim JE, Choi JY, Park RW, Yong Park J, Park HS, Sohn YS, Lee DS, Bae Lee E, Kim IS,. Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin. Biochem Biophys Res Commun 2002; 294: 940-8.
45. Kim JE, Jeong HW, Nam JO, Lee BH, Choi JY, Park RW, Park JY, Kim IS,. Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem 2002; 277: 46159-65.
46. Lee BH, Bae JS, Park RW, Kim JE, Park JY, Kim IS,. betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin. Exp Mol Med 2006; 38: 153-61.
47. Nam EJ, Sa KH, You DW, Cho JH, Seo JS, Han SW, Park JY, Kim SI, Kyung HS, Kim IS, Kang YM,. Up-regulated transforming growth factor beta-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through alpha v beta3 integrin: regulation by cytokines. Arthritis Rheum 2006; 54: 2734-44.
48. Zamilpa R, Rupaimoole R, Phelix CF, Somaraki-Cormier M, Haskins W, Asmis R, Lebaron RG,. C-terminal fragment of transforming growth factor beta-induced protein (TGFBIp) is required for apoptosis in human osteosarcoma cells. Matrix Biol 2009; 28: 347-53.
49. Clout NJ, Tisi D, Hohenester E,. Novel fold revealed by the structure of a FAS1 domain pair from the insect cell adhesion molecule fasciclin I. Structure 2003; 11: 197-203.
50. Witz CA, Takahashi A, Montoya-Rodriguez IA, Cho S, Schenken RS,. Expression of the alpha2beta1 and alpha3beta1 integrins at the surface of mesothelial cells: a potential attachment site of endometrial cells. Fertil Steril 2000; 74: 579-84.
51. Billings PC, Whitbeck JC, Adams CS, Abrams WR, Cohen AJ, Engelsberg BN, Howard PS, Rosenbloom J,. The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J Biol Chem 2002; 277: 28003-9.
52. Park YH, Ryu HS, Choi DS, Chang KH, Park DW, Min CK,. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int J Gynecol Cancer 2003; 13: 53-60.
53. Ahmed N, Riley C, Oliva K, Rice G, Quinn M,. Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer 2005; 92: 1475-85.